课题基金 / 基金详情

项目摘要

项目成果

Michael B Kastan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Clinical Trials Shared Resource (CTSR) is pivotal to the conduct of clinical research within the Duke Comprehensive Cancer Institute. This resource has evolved over the past 20 years from an embryonic one person protocol office to Its current staff of 16, centralizing protocol development, Protocol Review and Monitoring-System-(HRMS)-administration,-the Clinical-Trials-Quality-Assurance-and -Education-Program r and the Duke Comprehensive Cancer Institute (DCCI) Clinical Trials Office. The DCCI Clinical Trials Office Is a full-service operation offering start-to-finish clinical trials services to Cancer Institute members. The administrative functions (protocol administration, PRMS administration, E-research database of protocols, patient registration, quality assurance, safety surveillance desk and education of the CTSR staff) are all centralized. All DCCl protocols, regardless of sponsorship, are processed through the CTSR Office for review by the PRMS and abstracted into the central database (E-research). All DCCI protocol subjects are registered through the CTSR Office and the disease site clusters for entry in E-research (average annual total accrual based on last five years: 5659 patients on therapeutic trials; 14,420 subjects on non-therapeutic trials). Personnel providing start-up services are also housed in the CTSR Office. The Core Monitoring Team is staffed by members of the CTSR Office. Clinical trials operations are organized into disease and modality specific teams of Clinical Research Nurses (CRNs) and data managers (CRAs). The current teams, with total staffing over 100, are aligned with the existing programs of Breast and Ovarian Oncology, Experimental Therapeutics, Cancer Immunobiology, and Radiafion Oncology. The goal of the CTSR is to align its services in support ofthe scientific priorities ofthe Duke Comprehensive Cancer Institute. The CTSR is used mostly by peer-reviewed, DCCI members with highest priority given to peer-reviewed research. Charge-backs are on a sliding scale, with the biggest discounts provided to DCCl members conducting peer-reviewed research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the genomic and microenvironmental features of diffuse large B cell lymphoma in HIV + patients (Biospecimens/Biocohort)
  • 批准号:
    10619709
  • 项目类别:
  • 资助金额:
    $8.33万
  • 财政年份:
    2022
  • 负责人:
    Michael B Kastan
  • 依托单位:
Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
  • 批准号:
    8796446
  • 项目类别:
  • 资助金额:
    $6.17万
  • 财政年份:
    2011
  • 负责人:
    Michael B Kastan
  • 依托单位:
Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells
  • 批准号:
    8387220
  • 项目类别:
  • 资助金额:
    $25.93万
  • 财政年份:
    2011
  • 负责人:
    Michael B Kastan
  • 依托单位:
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
  • 批准号:
    8368238
  • 项目类别:
  • 资助金额:
    $10.83万
  • 财政年份:
    2011
  • 负责人:
    Michael B Kastan
  • 依托单位:
国内基金
海外基金
患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
  • 批准号:
    2026JJ81464
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    叶婷
  • 依托单位:
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
  • 批准号:
    2024KP61
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    余丹
  • 依托单位:
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
  • 批准号:
    51307073
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2013
  • 负责人:
    郭兴龙
  • 依托单位: